Active substance
Influenza a Virus a/Tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza a Virus a/Tasmania/787/2025 Cvr-388 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/Arizona/21/2025 Antigen (mdck Cell Derived, Propiolactone Inactivated)
3 products from 3 companies contain this in United States.
3 prescription onlyInjection, Suspension
Prescription only
Flucelvax15 ug/.5mL + 15 ug/.5mL + 15 ug/.5mLPrescription only Seqirus Inc. · Influenza a Virus a/Tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza a Virus a/Tasmania/787/2025 Cvr-388 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/Arizona/21/2025 Antigen (mdck Cell Derived, Propiolactone Inactivated)Flucelvax15 ug/.5mL + 15 ug/.5mL + 15 ug/.5mLPrescription only Sportpharm LLC · Influenza a Virus a/Tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza a Virus a/Tasmania/787/2025 Cvr-388 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/Arizona/21/2025 Antigen (mdck Cell Derived, Propiolactone Inactivated)Flucelvax15 ug/.5mL + 15 ug/.5mL + 15 ug/.5mLPrescription only ASCLEMED USA INC. · Influenza a Virus a/Tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza a Virus a/Tasmania/787/2025 Cvr-388 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/Arizona/21/2025 Antigen (mdck Cell Derived, Propiolactone Inactivated)
Same substance is not the same product. Strength, form, release mechanism and other ingredients all differ. Whether one can replace another is a decision for a pharmacist.